Highlights Kobayashi Pharmaceutical Co., Ltd. Deutsche Boerse AG

Equities

KOY

JP3301100008

Market Closed - Deutsche Boerse AG Other stock markets 07:05:21 05/07/2024 BST			5-day change	1st Jan Change
30 ^EUR	-1.32%		+1.35%	-28.91%

06-24	Kobayashi Pharmaceutical Co., Ltd.(TSE:4967) dropped from S&P Japan Mid Cap 100	CI
05-24	Japan companies hog the spotlight as hedge funds tout their top Asia picks	RE

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ex-dividend day for interim dividend	06-26	FA
A second Kobayashi Pharma Japan factory inspected over deaths	03-31	RE
Final dividend	12-27	FA
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.	11-08	CI
Kobayashi Pharmaceutical Co., Ltd's Equity Buyback announced on November 7, 2023, has closed with 1,924,600 shares, for ¥11,999.88 million.	11-07	CI
Kobayashi Pharmaceutical Co., Ltd. acquired Focus Consumer Healthcare, LLC.	06/10/23	CI
Ex-dividend day for interim dividend	28/06/23	FA
Kobayashi Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23	CI
Ex-dividend day for final dividend	28/12/22	FA
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 1, 2022.	02/11/22	CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 1, 2022, has closed with 1,150,602 shares, representing 1.49% for ¥9,991.92 million.	01/11/22	CI
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,265,800 shares, representing 1.64% for ¥9,999.82 million.	01/11/22	CI
Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	31/10/22	CI
Kobayashi Pharmaceutical Co., Ltd. Provides Earnings Guidance for the Full Year 2022	04/08/22	CI
Ex-dividend day for interim dividend	28/06/22	FA
Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 28, 2021.	14/02/22	CI
Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback announced on October 28, 2021, has expired with 883,300 shares, representing 1.13% for ¥7,999.54 million.	09/02/22	CI
Ex-dividend day for final dividend	28/12/21	FA
Kobayashi Pharmaceutical Co., Ltd. announces an Equity Buyback for 1,000,000 shares, representing 1.28% for ?8,000 million.	28/10/21	CI
Kobayashi Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	27/10/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Kobayashi Pharmaceutical Co., Ltd. Deutsche Boerse AG

Equities

KOY

JP3301100008

Highlights

Filters